Leidos shares rose 2.8% to $118.81 at the latest close. The latest filing gives that move a less tidy backdrop: revenue climbed to $4.6 billion in the three months ended July 3, but operating income fell to $514 million.
That is the central trade-off in this report. Leidos is selling more, but the profit kept from each dollar is shrinking. Operating margin fell to 11.3% from 13.4% in the comparable three months a year earlier, while diluted earnings per share declined to $2.81 from $3.01.
The company points to two costs tied to its financing and pension work, rather than a slowdown in revenue. One was a settlement loss from buying out its UK defined benefit pension plan. The other was higher interest expense after Leidos terminated a bridge loan and issued new senior notes.
Management put the explanation plainly in the 10-Q:
"The increase was primarily attributable to a $23 million settlement loss from the buy-out of our UK defined benefit pension plan and increased interest expense from the termination of our senior unsecured bridge loan facility and issuance of our $600 million and $800 million senior notes."
Leidos, Form 10-Q, August 4, 2026
In plain English, the profit line is carrying a bill from balance-sheet activity. The filing does not assign the entire profit decline to those items, but it identifies them as the primary reasons for the margin pressure.
Cash adds a second layer. Leidos ended the period with $748 million, down from $930 million a year earlier. Debt activity supplied a large inflow, while the prior year included $2.338 billion of cash paid in connection with the Entrust acquisition, net of cash acquired, making the cash comparison more about financing and deal timing than a simple operating cash scorecard.
The 10-Q describes that financing movement this way:
"The increase was primarily due to a net increase of $941 million in cash inflows from debt activity, consisting of proceeds from debt issuances and payments for borrowings and debt issuance costs."
Leidos, Form 10-Q, August 4, 2026
Leidos is therefore showing both cash support from new debt and a higher interest burden from that financing. The company also reported favorable working-capital changes and a higher free-cash-flow margin, which rose 5.7 percentage points on the comparable period. Inventory fell 74.2% to $94 million, an accounting movement whose cause the company does not disclose in the supplied filing receipts.
The annual record supplies some useful scale. Leidos' operating margin reached 12.3% in the year ended January 2, up from 4.0% in 2023, so the latest 11.3% reading sits below its most recent full-year level but well above that earlier trough. The latest filing is not a story of sales stopping; it is a story of financing-related costs arriving alongside sales growth.
At 10.7 times earnings and an enterprise value of $14.3 billion, the stock is priced around a business whose revenue is still expanding, but whose current profit conversion is moving in the opposite direction. That leaves one concrete comparison for Leidos' next quarterly report: whether operating margin is still below the 11.3% reported for the three months ended July 3.
